Hot Topics

Warner Chilcott Rises On Unusually High Volume (WCRX)

Warner Chilcott (Nasdaq:WCRX) is trading at unusually high volume Wednesday with 10.1 million shares changing hands. It is currently at two times its average daily volume and trading up 32 cents (+2.3%).

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Warner Chilcott (Nasdaq: WCRX) is trading at unusually high volume Wednesday with 10.1 million shares changing hands. It is currently at two times its average daily volume and trading up 32 cents (+2.3%) at $14.31 as of 4 p.m. ET.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Warner Chilcott has a market cap of $3.55 billion and is part of the health care sector and drugs industry. Shares are down 2.1% year to date as of the close of trading on Tuesday.

Warner Chilcott plc, a specialty pharmaceutical company, focuses on the development, manufacture, and promotion of branded pharmaceutical products in women's healthcare, gastroenterology, dermatology, and urology segments in North America and western Europe markets. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Warner Chilcott as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, expanding profit margins and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow. You can view the full Warner Chilcott Ratings Report.